Clinical Resources

Healeon Medical is committed to advancing science and therapeutics by providing support and resources to learn more about the various technologies and therapies that are resultant from their products. 

 

Healeon Medical's participation in sponsoring studies to help develop promising treatments and improve outcomes in a variety of applications is a large part of being a regenerative resource and one in which we take great pride in.

 

CURRENT STUDIES:

                                             

 

 

 

COVID-19 Treatment For Lung Complications

Healeon's safe and reliable CENTRIcyte 1000 system for isolating stem cells is currently             involved in several studies where intravenous administration of stem cells are administered to investigate treatment outcomes for COVID-19 patients, including one from our Chief Medical Officer, Dr. Robert Alexander, for lung complications associated with COVID-19. 

 

Here are the studies currently open or taking place:

https://clinicaltrials.gov/ct2/show/NCT04326036

 

https://clinicaltrials.gov/ct2/show/NCT04352803?term=Regeneris+medical&draw=2&rank=4

 

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1761322

 

 

 

BHT logo.png

CONTACT US:

Call:          858-348-8050

Email:        info@biminihealthtech.com

Orders:      orders@biminihealthtech.com

Follow Us on LinkedIn

 

 

 

HEALEON LLC

A BIMINI HEALTH TECH SUBSIDIARY

420 Stevens Avenue, Suite 220

Solana Beach, CA 91320

 

 

© 2020 by HEALEON LLC